HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial-Reference-Cited by-同舟云学术

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Published:2022-03-02 Issue:7 Volume:117 Page:1961-1971
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Korthuis P. Todd¹²^ORCID,Cook Ryan R.¹^ORCID,Lum Paula J.³,Waddell Elizabeth Needham¹²^ORCID,Tookes Hansel⁴,Vergara‐Rodriguez Pamela⁵,Kunkel Lynn E.¹,Lucas Gregory M.⁶,Rodriguez Allan E.⁴,Bielavitz Sarann¹^ORCID,Fanucchi Laura C.⁷,Hoffman Kim A.²,Bachrach Ken⁸,Payne Elizabeth H.⁹,Collins Julia A.⁹,Matthews Abigail⁹,Oden Neal⁹,Jacobs Petra¹⁰,Jelstrom Eve⁹,Sorensen James L.¹¹,McCarty Dennis¹²^ORCID

Affiliation:

1. Addiction Medicine Program Oregon Health and Science University Portland OR USA

2. Oregon Health and Science University‐Portland State University School of Public Health Portland OR USA

3. Division of HIV, ID and Global Medicine University of California San Francisco CA USA

4. Division of Infectious Diseases University of Miami Miller School of Medicine Miami FL USA

5. Ruth M. Rothstein CORE Center, Department of Psychiatry and Department of Internal Medicine Cook County Health Chicago IL USA

6. Johns Hopkins School of Medicine Baltimore MD USA

7. Division of Infectious Diseases and Center on Drug and Alcohol Research University of Kentucky Lexington KY USA

8. Tarzana Treatment Centers Tarzana CA USA

9. Emmes Company, LLC Rockville MD USA

10. National Institutes of Health National Institute on Aging Bethesda MD USA

11. Department of Psychiatry and Behavioral Sciences University of California San Francisco San Francisco CA USA

Funder

Agency for Healthcare Research and Quality

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15836

Reference31 articles.

1. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study

2. Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program

3. The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients

4. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis

5. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients;Addiction;2024-08-05

2. Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders;Annual Review of Medicine;2024-01-29

3. Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients;2024-01-24

4. Endogenous opiates and behavior: 2022;Peptides;2023-11

5. Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder;Substance Abuse;2023-10